Thursday, September 8, 2011

$BPAX Technical Analysis: UPDTAE - Trading in an ascending triangle

$BPAX after the big drop following the markets meltdown, finding support @ the 200MA area.
In the past 4 weeks, we can see a price consolidation creating an Ascending Triangle ,we can see on the daily chart bellow higher lows, as the traders are paying more for the same shares.
The $2.50 horizontal line use as a support / resistance since 2009, and this days we can see a fight around this point too.
The indicators showing a strength as both the MACD & the RSI-14 with a Positive Divergence that gave me the confidence that the direction is upward, is might trade inside the triangle, but breaking up the upper line (white line) will give us a big move upward and we can calculate it as the side of the triangle that will give us a $0.80 at the technical target is $3.60 at least....

Today. the price breakup the $2.50, but we need to see the price after the market closing,  the next point is breaking up the upper line around $2.80.

Just looking at the chart we can see that the price reach the target and touch the upper trend line of the triangle...with a large volume...that's give us more confidence that the break up is very close...
We might see a profit  taking @ this lots of technicians put a sell order just points under a resistance points...but, after a small correction we will have the uptrend even faster and will take the price to the next resistance point @ $3.20
I'm still long and waiting for the next step.

Disclosure: Long $BPAX

$BPAX have a close catalyst, BioSante will present at three healthcare conferences in September. The three presentations are as follows:
Wednesday, September 7, 2011 at 9:45 am EDT at the Stifel Nicolaus Healthcare Conference in Boston;
Monday, September 12, 2011 at 1:35 pm EDT at the Rodman & Renshaw Healthcare Conference in New York;
And on September 27, 2011 at 2:00 pm EDT at the JMP Securities Healthcare Conference in New York.

BioSante will provide a company overview at each conference, as well as an update on the LibiGel® (testosterone gel) Phase III clinical development program and planned NDA "new drug application" submission.


  1. what are you seeing now on BPAX TA? seems like we've just been stuck for a few days

  2. Andrew, you are right.
    Don't like the last three days, we get 3 doji's around the $2.80 resistant point, that's show us indicision...anf the price couldn't breakup the 50MA.
    In the other hand, the indicators still positive and want more upside...